Cytoreduction for advanced ovarian cancer in perspective

被引:8
作者
Hacker, NF
机构
关键词
D O I
10.1046/j.1525-1438.1996.06020159.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:159 / 160
页数:2
相关论文
共 18 条
[1]   DEBULKING SURGERY - DOES IT INCREASE THE QUALITY OF SURVIVAL [J].
BLYTHE, JG ;
WAHL, TP .
GYNECOLOGIC ONCOLOGY, 1982, 14 (03) :396-408
[2]   THE INFLUENCE OF TUMOR GRADE, DISTRIBUTION, AND EXTENT OF CARCINOMATOSIS IN MINIMAL RESIDUAL STAGE-III EPITHELIAL OVARIAN-CANCER AFTER OPTIMAL PRIMARY CYTOREDUCTIVE SURGERY [J].
FARIASEISNER, R ;
TENG, F ;
OLIVEIRA, M ;
LEUCHTER, R ;
KARLAN, B ;
LAGASSE, LD ;
BEREK, JS .
GYNECOLOGIC ONCOLOGY, 1994, 55 (01) :108-110
[3]  
Griffiths C T, 1975, Natl Cancer Inst Monogr, V42, P101
[4]   INTENSIVE SURGICAL AND CHEMOTHERAPEUTIC MANAGEMENT OF ADVANCED OVARIAN CANCER [J].
GRIFFITHS, CT ;
FULLER, AF .
SURGICAL CLINICS OF NORTH AMERICA, 1978, 58 (01) :131-142
[5]  
HACKER NF, 1983, OBSTET GYNECOL, V61, P413
[6]  
HACKER NF, 1992, OVARIAN CANC, V2, P351
[7]   CYTOREDUCTIVE SURGERY IN OVARIAN-CARCINOMA - FEASIBILITY AND MORBIDITY [J].
HEINTZ, APM ;
HACKER, NF ;
BEREK, JS ;
ROSE, TP ;
MUNOZ, AK ;
LAGASSE, LD .
OBSTETRICS AND GYNECOLOGY, 1986, 67 (06) :783-788
[8]   THE TREATMENT OF ADVANCED OVARIAN-CARCINOMA .1. CLINICAL-VARIABLES ASSOCIATED WITH PROGNOSIS [J].
HEINTZ, APM ;
VANOOSTEROM, AT ;
BAPTIST, J ;
TRIMBOS, MC ;
SCHABERG, A ;
VANDERVELDE, EA ;
NOOY, M .
GYNECOLOGIC ONCOLOGY, 1988, 30 (03) :347-358
[9]   THE INFLUENCE OF CYTOREDUCTIVE SURGERY ON RECURRENCE-FREE INTERVAL AND SURVIVAL IN SMALL-VOLUME STAGE-III EPITHELIAL OVARIAN-CANCER - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
HOSKINS, WJ ;
BUNDY, BN ;
THIGPEN, JT ;
OMURA, GA .
GYNECOLOGIC ONCOLOGY, 1992, 47 (02) :159-166
[10]  
LEUSLEY D, 1992, OVARIAN CANC, V2, P357